TCF7L2 polymorphisms, nut consumption, and the risk of metabolic syndrome: a prospective population based study
- PMID: 33436000
- PMCID: PMC7802263
- DOI: 10.1186/s12986-021-00542-7
TCF7L2 polymorphisms, nut consumption, and the risk of metabolic syndrome: a prospective population based study
Abstract
Background: The aim of this study was to investigate whether two variants of the TCF7L2 (rs7903146 and rs12255372) modify the association between nut consumption and the risk of metabolic syndrome (MetS). Additionally, the modifying effect of weight change during follow-up on these associations was investigated.
Material and methods: We prospectively studied 1423 participants of the Tehran Lipid and Glucose study aged 19-74 years who were followed-up for dietary assessment using a validated, semi-quantitative food frequency questionnaire. Multivariable-adjusted Cox regression was used to estimate hazard ratios (HRs) for MetS events. Genotyping was performed by Human Omni Express-24-v1-0 chip.
Results: Over a median 8.9 years of follow-up, 415 new cases of MetS were documented. The median nut consumption was 20.0 g/week (Interquartile Range (IQR): 8.6-38.9 g/week). Regarding the rs7903146 genotype, in carriers of T allele (CT + TT), highest tertile of nut consumption was associated with a reduced risk of MetS after adjusting for confounders (HR: 0.67 (0.50-0.91)). Regarding the rs12255372 genotype, highest versus lowest tertile of nut consumption in participants with T allele (GT + TT) resulted in 34% reduction of MetS risk after adjustment for confounders (HR: 0.66 (0.49-0.69)). After stratification by weigh change (< 7% or ≥ 7% weight gain), in individuals with ≥ 7% weight gain, highest tertile of nut consumption was associated with reduced risk of MetS among the risk allele of rs7903146. In the risk allele of rs12255372, among individuals with < 7% weight gain, third tertile of nuts intake reduced the risk of MetS, after adjustment for confounders.
Conclusion: Higher consumption of nuts may reduces the risk of MetS in T-risk allele of the TCF7L2 rs7903146 and rs12255372 variants and weight change may modify this association.
Keywords: Gene-diet interaction; Metabolic syndrome; Nuts; TCF7L2 polymorphisms; Weight change.
Conflict of interest statement
On behalf of all authors, the corresponding author hereby declares that there is no conflict of interest.
Figures
Similar articles
-
Socioeconomic and lifestyle factors modifies the association between nut consumption and metabolic syndrome incidence.Clin Nutr. 2021 Jun;40(6):4055-4064. doi: 10.1016/j.clnu.2021.02.013. Epub 2021 Feb 17. Clin Nutr. 2021. PMID: 33642144
-
Prospective Study of Nut Consumption and Incidence of Metabolic Syndrome: Tehran Lipid and Glucose Study.Nutrients. 2017 Sep 23;9(10):1056. doi: 10.3390/nu9101056. Nutrients. 2017. PMID: 28946607 Free PMC article.
-
TCF7L2 gene variants predispose to the development of type 2 diabetes mellitus among individuals with metabolic syndrome.Hormones (Athens). 2018 Sep;17(3):359-365. doi: 10.1007/s42000-018-0047-z. Epub 2018 Jul 3. Hormones (Athens). 2018. PMID: 29971604
-
Fruit and vegetable intake modifies the association between ultra-processed food and metabolic syndrome.Nutr Metab (Lond). 2024 Aug 1;21(1):58. doi: 10.1186/s12986-024-00831-x. Nutr Metab (Lond). 2024. PMID: 39090676 Free PMC article.
-
Inverse association of long-term nut consumption with weight gain and risk of overweight/obesity: a systematic review.Nutr Res. 2019 Aug;68:1-8. doi: 10.1016/j.nutres.2019.04.001. Epub 2019 Apr 11. Nutr Res. 2019. PMID: 31151081
Cited by
-
Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation.Nutrients. 2022 May 3;14(9):1918. doi: 10.3390/nu14091918. Nutrients. 2022. PMID: 35565885 Free PMC article. Review.
-
Effect of Nut Consumption on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis.Nutrients. 2023 May 19;15(10):2394. doi: 10.3390/nu15102394. Nutrients. 2023. PMID: 37242277 Free PMC article.
-
Metabolic syndrome in children and adolescents: definitions, epidemiology, pathophysiology, interventions, and challenges.Front Endocrinol (Lausanne). 2025 Jun 11;16:1512642. doi: 10.3389/fendo.2025.1512642. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40568560 Free PMC article. Review.
References
-
- Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi: 10.1161/CIRCULATIONAHA.109.192644. - DOI - PubMed
-
- Guo Y, Musani SK, Sims M, Pearson TA, DeBoer MD, Gurka MJ. Assessing the added predictive ability of a metabolic syndrome severity score in predicting incident cardiovascular disease and type 2 diabetes: the Atherosclerosis Risk in Communities Study and Jackson Heart Study. 2018;10:42. - PMC - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous